API

Lenvatinib (CAS No.: 417716-92-8) is used against thyroid cancer.
Our company produces 5000KG/M of Lenvatinib (CAS No.: 417716-92-8) every month, adequate inventory.
Our company sells more than 5000KG/M of Lenvatinib (CAS No.: 417716-92-8) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate (CAS No.: 856681-05-5) is a new type of weight loss drug.
Our company produces 5000KG/M of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate (CAS No.: 856681-05-5) every month, adequate inventory.
Our company sells more than 5000KG/M of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate (CAS No.: 856681-05-5) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Acrylic anhydride (CAS No.: 2051-76-5) Mainly used for the preparation of acrylic resin and organic synthesis.
Our company produces 500KG/M of Acrylic anhydride (CAS No.: 2051-76-5) every month, adequate inventory.
Our company sells more than 500KG/M of Acrylic anhydride (CAS No.: 2051-76-5) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Our company produces 5KG/M of (R)-Ambrisentan (CAS No.: 1007358-76-0) every month, adequate inventory.
Our company sells more than 5KG/M of (R)-Ambrisentan (CAS No.: 1007358-76-0) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

(S)-Timolol maleate (CAS No.: 26921-17-5) can block both β1 and β2 receptors with 8 times stronger effect than propranolol. It has no membrane stabilizing effect, no endogenous sympathomimetic activity, no direct inhibitory effect on the heart, and has obvious effect of reducing intraocular pressure.
Our company produces 200KG/M of (S)-Timolol maleate (CAS No.: 26921-17-5) every month, adequate inventory.
Our company sells more than 200KG/M of (S)-Timolol maleate (CAS No.: 26921-17-5) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Azithromycin (CAS No.: 83905-01-5) Mainly used for respiratory tract infections, urinary tract infections, skin and soft tissue infections and sexually transmitted diseases.
Our company produces 2000KG/M of Azithromycin (CAS No.: 83905-01-5) every month, adequate inventory.
Our company sells more than 1000KG/M of Azithromycin (CAS No.: 83905-01-5) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Zinc gluconate (CAS No.: 4468-02-4) Mainly used for infants, pregnant women due to zinc deficiency caused by growth retardation, malnutrition, anorexia, recurrent oral ulcer, skin acne and other diseases.
Our company produces 300 tons of Zinc gluconate (CAS No.: 4468-02-4) every month, adequate inventory.
Our company sells more than 300 tons of Zinc gluconate (CAS No.: 4468-02-4) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Ritalinic acid (CAS No.: 19395-41-6) Mainly used to treat hyperactivity syndrome in children.
Our company produces 100 tons of Ritalinic acid (CAS No.: 19395-41-6) every month, adequate inventory.
Our company sells more than 300 tons of Ritalinic acid (CAS No.: 19395-41-6) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.

Paclitaxel (CAS No.: 33069-62-4) Mainly used to treat ovarian cancer and breast cancer.
Our company produces 100 KG of Paclitaxel (CAS No.: 33069-62-4) every month, adequate inventory.
Our company sells more than 300 KG of Paclitaxel (CAS No.: 33069-62-4) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.